Africa Centre for Population Health
A new centre in South Africa will work to significantly reduce emerging HIV and TB co-infections.
One-third of the world’s population is latently infected with the bacteria that cause tuberculosis.
Scientists have found proteins in the body that promote lung inflammation which helps the bacteria that causes TB to spread throughout the lung.
South African scientists have found a way to single out the problematic parts of the bacteria causing TB that results in drug resistance.
African scientists have developed and patented a test for TB that overcomes two major challenges with current methods: it delivers quick results and is much cheaper.
Understanding what causes diseases is a life-and-death matter. It is a complicated issue that has generated a great deal of debate in the medical community.
Antiquated methods of treating TB included sunbathing. The modern-day equivalent is vitamin D supplements.
In countries such as South Africa with a high burden of TB and HIV, vitamin D could be an extremely effective and cheap weapon to include in the arsenal against TB and HIV.
A pair of lungs infected with TB.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
A new technique could help uncover previously unknown genetic factors contributing to susceptibility to TB.
Although one third of the world's population have the TB bacterium, the disease only develops in 10%, which may be linked to genetic factors.
Eradicating TB across the globe by 2035, as the World Health Organisation hopes to do, will only take place if the global funding and will improves.
More than 1.5 million people die of tuberculosis across the world every year. Although testing and screening has improved and more drugs are available, it is not enough to conquer the scourge.
Barriers to migrants' healthcare access must be lowered.
For many people in the UK, tuberculosis is a disease that’s been out of sight, out of mind for a number of years. Although it is low and middle-income countries that bear the burden of TB-related sickness…
Nearly 60% of multidrug-resistant tuberculosis' global burden occurs in the Asia-Pacific region.
DFAT Photo Library/ Flickr
Tuberculosis, or consumption as it used to be known, sounds like a disease that we’ve managed to fight off for good. But a drug-resistant strain of the bacteria that causes it is making a comeback, and…
Bangladesh: a melting pot of past, present and future.
Saud A Faisal
Despite low spending on health, a weak health system and widespread poverty, Bangladesh has achieved great strides in life…
A Treaty Protection Zone allows Papua New Guinea inhabitants and Australian nationals to mix freely on the outer Torres Strait islands.
Most Australians hear only periodic news items about outbreaks of tuberculosis, but globally the disease remains a top killer. And the emergence of drug-resistant strains pose a major challenge to tuberculosis…
The tuberculosis bacteria has a unique molecule on its surface that blocks a key part of the body’s defense. Research suggests…